In a move that significantly strengthens its international footprint and reinforces its commitment to scientific excellence, Complife is delighted to announce that Medcin has officially joined the Group.
This major strategic milestone marks a significant step forward in the future collaboration between two of the most respected names in the cosmetics, medical devices and healthcare products testing sectors.
By uniting Complife’s extensive international network and diverse testing suite with Medcin’s renowned scientific prestige and advanced in vitro and in vivo methodologies, the two entities establish an unparalleled framework for growth. This collaboration is built on a foundation of identical core values: a shared dedication to deep scientific rigor, regulatory integrity, and a client-centric approach to safety and efficacy testing.
For the Complife Group, welcoming Medcin Group represents an exciting new chapter in its ongoing expansion, offering a direct bridge to top-tier expertise and advanced capabilities in Latin America. For Medcin, joining forces with a globally integrated partner provides immediate access to an international pool of resources, state-of-the-art analytical technologies, and a broader geographic reach.
“The strategic collaboration with Medcin is a milestone of immense value for the Complife Group. Medcin is an established leader known for combining classic and highly innovative methodologies to scientifically validate the clinical benefits of raw materials, cosmetics, and medical devices,” says Massimo Valente, CEO of Complife Group. “By welcoming their talented scientific team and advanced laboratories into our network, we are not only expanding our global footprint but also unlocking exciting new opportunities to serve our clients worldwide with a deeply integrated, world-class service portfolio.”
Sergio Schalka, CEO of the Medcin Group announces: “In Complife, we have found a partner that shares our DNA—a commitment to science, a passion for innovation, and an unwavering focus on high-quality methods to evaluate product safety and efficacy. Joining the Complife Group enables us to expand our methodologies globally and access new international markets much faster. We are excited to embark on this journey with our new global colleagues”.
“Joining the Complife group will give us the opportunity to offer our clients cutting-edge international methodologies and regulatory access to markets in Europe and other continents. This new step for MEDCIN is also a recognition of our history as a Brazilian leader in clinical and preclinical research,” says Flávia Addor, scientific director of the Medcin Group.
Moving forward, both companies will maintain their deep-rooted focus on helping clients elevate their business in the health and personal care markets. Together, Complife and Medcin will continue to guide the cosmetics industry toward safer, more effective, and rigorously proven products.
About Complife Group
Born from a legacy of over 30 years of experience in wellness, beauty, and safety testing, Complife is a global group providing comprehensive consulting and analytical services for cosmetics, nutritional products, medical devices, and pharmaceuticals. With an international network of laboratories and full-service consulting capabilities, Complife helps businesses demonstrate product safety, tolerability, and efficacy, ensuring compliance with global regulatory standards.
Website: www.complifegroup.com
About Medcin
Medcin is a leading scientific and clinical research center dedicated to the safety and efficacy testing of cosmetics, dermocosmetics, medical devices and nutraceuticals. Renowned for its scientific excellence and rigorous methodologies, Medcin combines classic and cutting-edge in vivo and in vitro techniques to scientifically prove the clinical benefits and action mechanisms of products for the global personal care and health industries.
Website: www.grupomedcin.com.br
